With a high-transmission status, the CDC recommends avoiding “non-essential indoor activities” and wearing a well-fitting mask regardless of vaccination status, among other tips.
“These positive data show efficacy of our protein-based, bivalent adjuvanted vaccine candidate in an environment of high Omicron variant circulation,” Roger Connor, president of GSK Vaccines, said in a press release. “Our vaccine candidate has the potential to make an important contribution to public health as the pandemic evolves further. We are looking forward to the discussions with regulatory authorities with the aim of making our vaccine candidate available later this year.”
The stage 2 of the phase 3 COVID-19 vaccine trial VAT08 included more than 13,000 participants 18 years of age and older showed an efficacy of 64.7% against symptomatic COVID-19 and 72% efficacy in Omicron-confirmed symptomatic cases.
In previous seropositive populations, the Sanofi-GSK vaccine candidate showed an overall efficacy of 75.1% against symptomatic infection and 93.2% in Omicron-confirmed symptomatic cases, according to a sequencing analysis performed.
Bem Vindos a este espaço onde compartilhamos um pouco da realidade do Japão à todos aqueles que desejam visitar ou morar no Japão. Aqui neste espaço, mostramos a realidade do Japão e dos imigrantes. O nosso compromisso é com a realidade. Fique por dentro do noticiário dos principais jornais japoneses, tutoriais de Faça você mesmo no Japão e acompanhe a Série Histórias de Imigrantes no Japão. Esperamos que goste de nossos conteúdos, deixe seu like, seu comentário, compartilhe e nos ajudar você e à outras pessoas. Grande abraço, gratidão e volte sempre!
It has new aidias,news, about education , motivation, social, historical, culture, marketing creation new aidias education of language science culture and history
You must be logged in to post a comment.